RNAiScience logo
Scientist in lab coat examining specimen for RNAi research
Scientist in lab coat examining specimen for RNAi research

RNAi Science

A living library of educational, scientific, and clinical resources

Alnylam Medical Information Hub

Overview

This website was created for US healthcare professionals to provide access to educational, clinical, and scientific information about Alnylam's therapeutic areas and the science of RNAi behind our FDA-approved products and clinical pipeline. Read on or connect with us to learn more about our science.

  • Use the “Search” feature to discover educational content based on key terms
  • More than one search term is recommended to yield the most relevant results
  • By searching, you confirm that your query is unsolicited.

News & Latest Resources

Prime Point-of-Care Playbook

ATTRv Amyloidosis Hub

This Resource Center, provided by PRIME Education and supported by Alnylam Pharmaceuticals, contains downloadable resources and practical tools to support coordinated, multidisciplinary care and facilitate timely, comprehensive diagnostic evaluations for patients with ATTRv (also known as hATTR) amyloidosis.

Posted: August 05, 2024
Keywords: 
amyloidosis
ATTRv
diagnosis
hATTR
Bookmark this pageBookmark this page

This site is intended for US healthcare professionals.
© 2025 Alnylam Pharmaceuticals, Inc. All rights reserved.
MED-US-ALL-2400001

RNAI Logo

You are now leaving this site and being directed to a third-party website that is not maintained by Alnylam. Alnylam does not endorse and is not responsible for content or maintenance of third-party websites.

ContinueCancel

RNAI Logo

You are now leaving this site and being directed to another Alnylam website.

ContinueCancel

RNAI Logo

Intended for US healthcare professionals. This site is intended to provide balanced, evidence-based information to support scientific exchange. It is not intended to provide medical advice or recommendations for clinical practice.

Information about investigational therapeutics or investigational uses of approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of FDA approval.

Alnylam does not recommend or suggest use of its products in any manner inconsistent with the approved Prescribing Information.

Are you a healthcare professional practicing in the United States?

I confirm I am a US healthcare professional

I am a US payer or healthcare decision maker

I am not a US healthcare professional, or a US payer or healthcare decision maker

I am an Alnylam Team Member